RESUMO
PURPOSE OF REVIEW: This article reviews PTPS demographics, diagnosis, pathophysiology, surgical and anesthetic techniques, and their role in preventing PTPS along with updated treatment options. RECENT FINDINGS: Post-thoracotomy pain syndrome (PTPS) can be incapacitating. The neuropathic type pain of PTPS is along the incision site and persists at least 2 months postoperatively. There is a wide reported range of prevalence of PTPS. There are several risk factors that have been identified including surgical technique and younger age. Several surgical and anesthetic techniques have been trialed to reduce pain after thoracotomy. Multimodal pain control is the suggested long-term treatment plan for patients with PTPS. There are several factors that can be modified to reduce pain and incidence of PTPS during the perioperative period and the use of multimodal analgesia is suggested for the treatment of PTPS.
Assuntos
Analgesia , Neuralgia , Dor no Peito/etiologia , Humanos , Neuralgia/etiologia , Dor Pós-Operatória/diagnóstico , Dor Pós-Operatória/etiologia , Dor Pós-Operatória/terapia , Toracotomia/efeitos adversosRESUMO
No disponible
Assuntos
Humanos , Masculino , Pioderma Gangrenoso/diagnóstico , Carcinoma de Células Escamosas , Prednisona/administração & dosagem , Pioderma Gangrenoso/diagnóstico por imagem , Pioderma Gangrenoso/tratamento farmacológico , Diagnóstico Diferencial , Úlcera Cutânea , Ultrassonografia , Tomografia Computadorizada EspiralRESUMO
Insulin-like growth factor binding protein 2 (IGFBP-2) may represent a critical link between body composition and insulin sensitivity. We investigated the relationship between circulating IGFBP-2 levels, body composition, insulin sensitivity, energy intake and physical activity in children with obesity. Children were recruited via the Weight Management Service at the Royal Children's Hospital, Melbourne, as part of the Childhood Overweight BioRepository of Australia (COBRA). Comprehensive anthropometric, biochemical and environmental data were collected and compared to serum IGFBP-2 levels (measured by enzyme-linked immunosorbent assay). Multiple regression modelling was used to assess the influence of circulating IGFBP-2 levels on anthropometric and biochemical measures. One hundred and ninety-four children were included in this study (46% male). Circulating IGFBP-2 negatively correlated with age, anthropometric measures, blood pressure and insulin concentration. Positive associations were observed between insulin sensitivity index-homeostasis model assessment (ISI-HOMA) and serum IGFBP-2. In multiple regression modelling, IGFBP-2 significantly contributes to variance in systolic blood pressure (-19%, P < 0.05), circulating triglycerides (-16%, P < 0.05) and ISI-HOMA (18%, P < 0.05). No associations were observed between dietary energy intake or physical activity and IGFBP-2 levels. Circulating IGFBP-2 levels in children with obesity correlate inversely with body mass and markers of metabolic dysfunction, and positively with insulin sensitivity. These findings suggest that reduced levels of IGFBP-2 may play an important role in the pathogenesis of obesity complications in early life.
Assuntos
Índice de Massa Corporal , Proteínas de Transporte/sangue , Resistência à Insulina , Proteína 2 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Insulina/metabolismo , Obesidade/complicações , Adolescente , Fatores Etários , Austrália , Glicemia/metabolismo , Pressão Sanguínea , Composição Corporal , Criança , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Proteína 2 de Ligação a Fator de Crescimento Semelhante à Insulina/deficiência , Masculino , Obesidade/sangue , Análise de Regressão , Fatores de Risco , Triglicerídeos/sangueRESUMO
No disponible
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Queixo/lesões , Atenção Primária à Saúde , Antibacterianos/uso terapêutico , Eritema/diagnóstico , Eritema/tratamento farmacológico , Superinfecção/complicações , Arthrodermataceae , Administração Tópica , Diagnóstico Diferencial , Superinfecção/tratamento farmacológicoRESUMO
No disponible
Assuntos
Humanos , Feminino , Criança , Nevo Pigmentado/complicações , Eczema/diagnóstico , Hipopigmentação/diagnóstico , Eritema/diagnóstico , Prurido/etiologiaRESUMO
No disponible
Assuntos
Humanos , Feminino , Idoso de 80 Anos ou mais , Xantomatose/diagnóstico , Neoplasias da Mama/complicações , Diagnóstico Diferencial , Complicações Pós-Operatórias , Quimiorradioterapia/efeitos adversosAssuntos
Neoplasias da Mama/radioterapia , Neoplasias Induzidas por Radiação/etiologia , Radioterapia Adjuvante/efeitos adversos , Xantomatose/etiologia , Idoso de 80 Anos ou mais , Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Biópsia , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/cirurgia , Terapia Combinada , Diagnóstico Diferencial , Feminino , Humanos , Mastectomia , Mastite/diagnóstico , Recidiva Local de Neoplasia/diagnósticoRESUMO
La dermatitis anular liquenoide de la infancia es una entidad de etiología desconocida que forma parte del grupo de las dermatosis liquenoides. Afecta sobre todo a niños y adolescentes, mostrando unas características clinicopatológicas definidas que permiten su diagnóstico. Presentamos 2 nuevos casos de dermatitis liquenoide anular de la infancia en 2 niñas de 4 y 2 años y medio, respectivamente, que presentan las características clínicas clásicas de esta entidad. A diferencia del resto de casos publicados el examen histopatológico mostró un infiltrado inflamatorio liquenoide situado principalmente en el techo de las papilas dérmicas, y no en la punta de las crestas epidérmicas. En ambos casos las lesiones regresaron espontáneamente sin necesidad de tratamiento
Annular lichenoid dermatitis of youth is a lichenoid dermatosis of unknown etiology. It mostly affects children and adolescents and has well-defined clinical and histological characteristics that permit a diagnosis. We present 2 new cases of annular lichenoid dermatitis of youth with classical clinical features in 2 girls, aged 2 and 4 years. The histologic findings, however, differed from those reported in the literature in that the lichenoid inflammatory infiltrate was located primarily at the top of the dermal papillae and not at the tips of the rete ridges. In both cases, the lesions regressed spontaneously without treatment
Assuntos
Humanos , Feminino , Lactente , Erupções Liquenoides/diagnóstico , Micose Fungoide/diagnóstico , Biópsia , Diagnóstico Diferencial , Dermatomicoses/diagnósticoRESUMO
Annular lichenoid dermatitis of youth is a lichenoid dermatosis of unknown etiology. It mostly affects children and adolescents and has well-defined clinical and histological characteristics that permit a diagnosis. We present 2 new cases of annular lichenoid dermatitis of youth with classical clinical features in 2 girls, aged 2 and 4 years. The histologic findings, however, differed from those reported in the literature in that the lichenoid inflammatory infiltrate was located primarily at the top of the dermal papillae and not at the tips of the rete ridges. In both cases, the lesions regressed spontaneously without treatment.
Assuntos
Erupções Liquenoides/patologia , Pré-Escolar , Feminino , HumanosRESUMO
BACKGROUND: Individuals with intellectual disabilities are at increased risk of becoming overweight or obese. This is particularly evident in people with trisomy 21 and Prader-Willi syndrome (PWS). Although metabolic factors are known to contribute to obesity in trisomy 21 and hyperphagia plays a primary role in PWS, hyperphagia has not yet been investigated as a possible contributing factor to obesity in trisomy 21. METHODS: Participants comprised three diagnostic groups: trisomy 21 (T21 group), PWS (PWS group) and lifestyle-related obesity (LRO group). They were required to be aged 6-18 years and have a body mass index over the 85th percentile for age and gender. A parent of each participant completed the Hyperphagia Questionnaire and the Children's Leisure Activity Study Survey. Mean scores for each domain and across all domains of the Hyperphagia Questionnaire and the Children's Leisure Activity Study Survey were compared between diagnostic groups using linear regression analysis. RESULTS: The study group consisted of 52 young people (23 men and 29 women) aged 6-18 years (mean 12.5 years; T21 group n = 17, PWS group n = 16 and LRO group n = 19). As hypothesised, the PWS group had the highest mean scores across all domains of the Hyperphagia Questionnaire, and the LRO group had the lowest. Food-seeking behaviour was more pronounced in the PWS group than the T21 group (mean score 13.2 vs. 8.6, p = 0.008). The LRO group spent more hours per week engaged in physical activity (14.7) in comparison with the other groups (9.6 and 9.7), whereas between the groups, differences in time spent in sedentary activities were less pronounced. CONCLUSIONS: Preoccupation with food and low levels of physical activity may contribute to the development of overweight and obesity in some individuals with trisomy 21. These factors warrant consideration in the clinical context.
Assuntos
Síndrome de Down/complicações , Hiperfagia/complicações , Obesidade Infantil/etiologia , Síndrome de Prader-Willi/complicações , Comportamento Sedentário , Adolescente , Criança , Feminino , Humanos , Hiperfagia/etiologia , MasculinoRESUMO
Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder, with many women initially presenting during adolescence. Diagnosis during this period is particularly challenging, yet many emphasize the importance of an early diagnosis given the long-term metabolic and reproductive health consequences associated with the syndrome. The objective of this study was to review the current literature to determine whether the diagnostic label 'PCOS' is necessary to effectively manage adolescent girls presenting with features of the syndrome. A literature search was conducted (PubMed, Medline, Informit Health and the Cochrane Database of Systematic Reviews) identifying papers addressing the diagnosis and management of PCOS during adolescence. Articles were selected based on date of publication, relevance of material and the quality of evidence presented. A total of 427 papers were screened, with 40 of these selected from the initial search. A subsequent 154 were included from manual review of reference lists from key papers identified in the initial search. Current guidelines recommend treating the individual manifestations of PCOS. In doing so, there is good evidence identifying that this approach adequately targets the underlying metabolic and reproductive changes associated with the syndrome. This suggests that providing a diagnostic label of PCOS is not actually necessary to effectively manage adolescent girls with features of this syndrome.
Assuntos
Saúde do Adolescente , Síndrome do Ovário Policístico/diagnóstico , Adolescente , Feminino , Humanos , Síndrome do Ovário Policístico/metabolismo , Síndrome do Ovário Policístico/terapiaRESUMO
No disponible
Assuntos
Adulto , Feminino , Humanos , Doenças Mamárias/induzido quimicamente , Doenças Mamárias/complicações , Neoplasias da Mama/complicações , Neoplasias da Mama/cirurgia , Derme/anatomia & histologia , Derme/patologia , Derme , Mamoplastia/instrumentação , Mama/cirurgia , Hiperpigmentação/cirurgia , Mama/lesões , Mamoplastia/métodos , Hiperpigmentação/complicações , Cicatriz/complicações , Cicatriz/cirurgia , Imageamento por Ressonância Magnética/métodos , Fibrose/complicações , Fibrose/cirurgia , Fibrose , Mastite/complicaçõesRESUMO
BACKGROUND/OBJECTIVES: Adenovirus-36 (Adv-36) infection is associated with exaggerated adipogenesis in cell culture and the development of obesity in animal models and humans, but a causal relationship remains unproven. Our objective was to determine whether serological evidence of Adv-36 infection in childhood and/or adulthood is associated with adult obesity. SUBJECTS/METHODS: Paired plasma concentrations of Adv-36 antibodies were measured by a novel enzyme-linked immunosorbent assay in a subgroup (n=449) of the Cardiovascular Risk in Young Finns Study in childhood (mean age 11.9 years) and adulthood (mean age 41.3 years). The study group included (1) individuals who had maintained normal-weight status (2) those who became obese adults from a normal-weight status in childhood and (3) those that were overweight/obese as a child and obese as an adult. RESULTS: Mean (s.d.) time between baseline and follow-up was 29.4 (3.2) years (range 21-31 years). A total of 24.4% of individuals who were normal weight throughout life were seropositive for Adv-36 during child and/or adulthood as compared with 32.3% of those who became obese adults (P=0.11). Those who became obese in adulthood were more likely to be Adv-36 seropositive as adults compared with those who maintained normal weight (21.3% vs. 11.6%, P=0.02). This difference was mediated by a decline in Adv-36 seropositivity between child and adulthood in those maintaining normal weight. No differences were observed in body mass index across the life course, nor in waist circumference in adult life, between those who were Adv-36 seronegative or seropositive at any age. CONCLUSIONS: Individuals who gained weight across the life course were more likely to be Adv-36 seropositive in adult life than those who did not gain weight. However, analysis of change in weight status in relation to Adv-36 positivity did not support a causal role for Adv-36 in the development of obesity.
Assuntos
Infecções por Adenoviridae/complicações , Adenoviridae/isolamento & purificação , Doenças Cardiovasculares/etiologia , Obesidade/etiologia , Infecções por Adenoviridae/fisiopatologia , Adolescente , Adulto , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/prevenção & controle , Criança , Pré-Escolar , Estudos Transversais , Feminino , Humanos , Estudos Longitudinais , Masculino , Obesidade/sangue , Obesidade/fisiopatologia , Fatores de RiscoRESUMO
Psychiatric illness in the paediatric population is increasing and the weight effect of medications for these problems is often unclear. A comprehensive literature search was undertaken to identify studies reporting weight in relation to antipsychotic and antidepressant use in children and adolescents. From 636 articles, 42 were selected for review. Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) do not cause weight gain and may lead to improvements in weight status over the short, but not, long term. Antipsychotics were generally associated with weight gain. In drug comparison studies, risperidone had a larger weight gain effect than lithium, divalproex sodium and pimozide. Studies assessing the weight-protective effects of augmentation therapy with metformin or topiramate show less weight gain with addition of these agents. In conclusion, prescribing of SSRIs and SNRIs may be associated with improvements in weight status in children and adolescents but trials assessing their use in obesity, outside of established psychiatric illness, are limited and still experimental. Youth prescribed antipsychotic medication should be monitored for exaggerated weight gain and in those where obesity is a pre-existing concern agents other than olanzapine, clozapine and risperidone may be advantageous.
Assuntos
Antidepressivos/administração & dosagem , Antipsicóticos/administração & dosagem , Transtornos Mentais/tratamento farmacológico , Obesidade Infantil/induzido quimicamente , Aumento de Peso/efeitos dos fármacos , Adolescente , Antidepressivos/efeitos adversos , Antipsicóticos/efeitos adversos , Criança , Esquema de Medicação , Humanos , Obesidade Infantil/prevenção & controle , Medição de Risco , Fatores de RiscoAssuntos
Implantes de Mama/efeitos adversos , Mastite/diagnóstico por imagem , Silicones/efeitos adversos , Adulto , Diagnóstico Diferencial , Eritema Endurado/diagnóstico , Feminino , Hidradenite Supurativa/diagnóstico , Humanos , Mamoplastia , Mastectomia , Mastite/induzido quimicamente , Mastite/diagnóstico , Mastite/cirurgiaRESUMO
No disponible
Assuntos
Humanos , Feminino , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/cirurgia , Nariz/cirurgia , Neoplasias Nasais/cirurgia , Procedimentos de Cirurgia Plástica/métodos , Retalhos Cirúrgicos , Estética , Técnicas de SuturaRESUMO
The ubiquitous nature of the IGF system, expressed early in embryonic development throughout postnatal and adult life, indicates a key role for this system in human biology. Studies of transgenic mice over-expressing components of the IGF system or mice with disruptions of the same genes have clearly shown that the IGF system plays an important role in vivo. The activity of the IGF ligands, elicited via their receptors and transduced by various intracellular signal pathways, is modulated by the IGFBPs. Among all the IGFBPs, IGFBP-2 has been implicated in the regulation of IGF activity in the nervous system, peripheral tissue and organs. Besides binding to IGFs in the circulation, these IGF-regulatory activities of IGFBP-2 involve interactions with components of the extracellular matrix and cell surface proteoglycans and integrin receptors. In addition to these "local" peri-cellular activities of IGFBP-2, it became evident that IGFBP-2 exerts other key functions within the cell. In the cytoplasm IGFBP-2, most likely in the absence of the IGFs, interacts with regulatory proteins including transcription factors and cytoplasm-nuclear transporters. Within the nucleus IGFBP-2, directly or indirectly, promotes transcriptional activation of specific genes. These intrinsic activities of IGFBP-2 are mediated via specific functional domains. All of these IGFBP-2 activities, intrinsic or dependent on IGFs, contribute to its functional roles in growth/development, metabolism and malignancy as evidenced by studies in IGFBP-2 animal models and also by many in vitro studies. Finally, preclinical studies have demonstrated that IGFBP-2 administration can be beneficial in improving metabolic responses (inhibition of adipogenesis and enhanced insulin sensitivity), while blockade of IGFBP-2 appears to be an effective approach to inhibiting tumor growth and metastasis.